Literature DB >> 22647625

[Ischemic retinopathy in Takayasu disease].

Inès Loukil1, Nadia Mallouch, Firas Hachicha, Rim Bhiri, Ahmad Hijazi, Amel Jeddi Blouza.   

Abstract

PURPOSE: To evaluate the clinical features and fundus fluorescein angiography findings of Takayasu retinopathy. PATIENTS AND METHODS: A retrospective, descriptive study of 11 patients with proven Takayasu arteritis and ischemic retinopathy examined at the Department of Ophthalmology of Rabta hospital (Tunisia). All patients underwent a complete ophthalmic examination and fluorescein angiography. Systemic corticotherapy and immunosuppressive therapy was prescribed in all patients. Green laser photocoagulation was performed in cases with ischemic retinopathy.
RESULTS: The mean follow-up period was 64.2 months (range, 8-82 months). The mean age at diagnosis of ischemic retinopathy was 27.9 years (range, 21-39 years). The male-to-female ratio was 0.1. We observed all stages of Takayasu's retinopathy. The best-corrected visual acuity ranged from 4/10 to 10/10. Clinical improvement was notes in 54.5 of all cases. Blindness occurs in only one case with severe ischemic retinopathy.
CONCLUSION: The ischemic retinopathy in Takayasu disease is due to a severe hypoperfusion of the retinal artery. A careful and regular clinical and angiographic monitoring must be performed to prevent blindness.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22647625     DOI: 10.1016/j.lpm.2012.02.047

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  An Unusual Association: Takayasu's Arteritis and Tubulointerstitial Nephritis and Uveitis Syndrome.

Authors:  Abir Derbel; Mariam Ghribi; Sameh Marzouk; Zouhir Bahloul
Journal:  Eur J Case Rep Intern Med       Date:  2020-11-17

2.  Recovery from Repeated Sudden Hearing Loss in a Patient with Takayasu's Arteritis Treated with Hyperbaric Oxygen Therapy: The First Report in the Literature.

Authors:  Massimo Ralli; Antonio Greco; Vincenzo Falasca; Giancarlo Altissimi; Mario Tombolini; Rosaria Turchetta; Sara de Fazio; Marco de Vincentiis; Giancarlo Cianfrone
Journal:  Case Rep Otolaryngol       Date:  2017-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.